Multiple System Atrophy and stem cell therapy
Multiple system atrophy moves fast, affecting balance, blood pressure, bladder and speech at once, and families often feel there is little left to try. Our approach focuses on supporting the nervous system.
Medically reviewed by:Javier E. Garrido L.MD, MSc
On this page
What is multiple system atrophy?
Multiple system atrophy (MSA) is a rare, progressive neurodegenerative disease that affects movement and the autonomic nervous system, which controls blood pressure, heart rate, bladder function and digestion. A protein called alpha-synuclein builds up in the support cells of the brain, and nerve cells in several brain regions are lost. MSA has two main types: MSA-P, with Parkinson-like stiffness and slowness, and MSA-C, with problems of balance and coordination. Symptoms usually begin in a person’s 50s or 60s. Early on, MSA can look like Parkinson’s, so specialist evaluation matters.

At Regeneration Clinic Panama, we take an individualized approach to your care. Our medical team will review your condition, medical history, and individual needs to help you understand your treatment options.
Book a ConsultationCommon signs and symptoms
Autonomic symptoms such as dizziness on standing or bladder changes often appear early, sometimes before movement problems.
- Dizziness or fainting when standing up
- Stiffness and slow movement
- Unsteady walking and poor coordination
- Slurred or quiet speech
- Bladder urgency or incontinence
- Erectile dysfunction
- Acting out dreams during sleep
- Difficulty swallowing
- Noisy breathing or snoring at night
How MSA is usually treated
Today, MSA care focuses on managing symptoms, because no treatment yet slows the disease itself. Medicines such as fludrocortisone, midodrine, droxidopa and pyridostigmine help with low blood pressure on standing, along with extra salt, fluids and compression garments. Levodopa may ease stiffness and slowness in some people, usually modestly. Physical, speech and swallowing therapy, bladder care and sleep studies support daily life. Many families keep looking for additional options to discuss with their neurologist.

How stem cell therapy works for MSA
In MSA, inflammation and the buildup of alpha-synuclein damage nerve cells and the cells that support them. Mesenchymal stem cells reduce inflammation, release growth factors that support nerve cells and help regulate the immune response in the nervous system. We use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords as part of selected personalized protocols. They are delivered by IV and, in selected cases, by other routes your physician recommends. Mesenchymal stem cells work alongside the symptom care you already receive.
Every patient with multiple system atrophy has a different history and set of needs, so we start with a full evaluation. Your physician reviews your history, symptoms, previous treatments and test results before deciding whether a regenerative protocol is appropriate. When it is, cell therapy becomes one part of a personalized care plan.
Important: cellular therapy is an evolving area of medicine. Outcomes vary, and treatment decisions are made individually after a medical assessment.
What the research says
These studies were published by independent research teams. Their results are separate from our own patient outcomes.
- Source link
A randomized, placebo-controlled trial in 33 people with the cerebellar type of MSA gave the person’s own bone marrow mesenchymal stem cells into an artery and a vein, or placebo, with one year of follow-up.
Neurological scores worsened less in the mesenchymal stem cell group than with placebo, and the artery route caused small areas of damage visible on MRI.
- Source link
A phase 1/2 study gave 24 people with early MSA their own fat-derived mesenchymal stem cells into the spinal fluid at rising dose levels.
There were no serious treatment-related events, the highest dose caused back and leg pain, and progression was slower than in a matched historical group; there was no placebo group.
- Source link
A 2026 systematic review pooled seven studies with 123 people with MSA who received mesenchymal stem cells by different routes.
Side effects were common and mostly mild and short-lived, several studies suggested slower progression, and the authors call for larger controlled trials.
Research in MSA is early and limited to small studies of bone marrow and fat-derived mesenchymal stem cells, so results should be read with caution.
Who may consider this
A personalized evaluation may be right for you if you:
- Have a diagnosis of probable or possible MSA from a movement disorder specialist
- Are in an earlier stage and can still walk, with or without support
- Want to add a supportive option to your current symptom care
- Have blood pressure managed well enough for travel, as your physician advises
- Are ready to share autonomic tests, imaging and neurology records
Our medical team decides suitability after reviewing each case.
What to expect
Before Treatment
Our team reviews your medical history and diagnostic information. We may recommend extra tests to understand your current health and whether you may be a candidate.
During Your Stay
If you are eligible, our medical team guides you through each stage of treatment and provides clinical support throughout.
After Treatment
We follow up at 1, 3, 6, 9 and 12 months after treatment and adjust your plan as needed.

Schedule a personalized consultation to discuss your medical history, treatment goals, and potential care options.
Book a ConsultationRelated articles
Real Patients. Real Results.
Patient stories share individual experiences. Results vary, and no outcome is promised.


- Takes less than 2 minutes
- No commitment
- Takes less than 2 minutes
- No commitment
Your questions
Read Full FAQAnswers about safety, cost and what to expect.
MSA often affects blood pressure and bladder early, progresses faster and responds less to levodopa. Because the two can look alike at first, our physicians review your full neurological history before any recommendation.
No outcome is promised. Small studies suggest slower progression in some people, and larger controlled trials are still needed. Mesenchymal stem cells reduce inflammation and support nerve cells, and results vary from person to person.
Many people with MSA travel with a companion and a plan for blood pressure. Our physicians review your symptoms and medicines before you book and advise on hydration, compression and airport assistance.
Mesenchymal stem cells are recognized for medical use in the European Union and Australia, with hundreds of clinical trials underway worldwide. In December 2024, the FDA approved the first mesenchymal stem cell product in the United States, for steroid-refractory acute graft-versus-host disease in children. For other conditions, mesenchymal stem cell therapy is not FDA-approved in the US.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance. Results vary from patient to patient and no outcome is promised.

Still have a question?
Ask us directly. A patient advocate will reply personally.






